oral small molecule c5 inhibitor
oral small molecule c5 inhibitor: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| RA PHARMACEUTICALS, INC. (RARX) | Preclinical |
Get deeper analysis on oral small molecule c5 inhibitor
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis